Substrate | Strain | CDW (gL−1)a | PHAa (wt%) | PHA concentration (mg L−1)a | Percent increaseb |
---|---|---|---|---|---|
Sodium butyrate | LSBJ | 0.80 ± 0.03 | 0.38 ± 0.05 | 3.04 ± 0.27 | 3750 |
RSC02 | 0.85 ± 0.03 | 13.7 ± 0.95 | 117 ± 11.1* | ||
Pentanoic acid | LSBJ | 0.76 ± 0.05 | 0.23 ± 0.02 | 1.92 ± 0.42 | 6360 |
RSC02 | 1.14 ± 0.04* | 11.1 ± 1.01 | 124 ± 7.25* | ||
Hexanoic acid | LSBJ | 0.85 ± 0.01 | 5.47 ± 0.97 | 44.8 ± 6.13 | 485 |
RSC02 | 1.06 ± 0.01* | 27.3 ± 4.28 | 262 ± 59.0* | ||
Heptanoic acid | LSBJ | 0.93 ± 0.01 | 23.4 ± 0.48 | 198 ± 4.27 | 61 |
RSC02 | 1.02 ± 0.06 | 30.2 ± 2.28 | 319 ± 22.8* | ||
Sodium octanoate | LSBJ | 1.22 ± 0.05 | 44.5 ± 8.68 | 543 ± 110 | 1.10 |
RSC02 | 1.03 ± 0.01* | 54.1 ± 1.06 | 549 ± 12.5 | ||
Decanoic acid | LSBJ | 1.23 ± 0.05 | 29.3 ± 2.15 | 281 ± 152 | 115 |
RSC02 | 1.49 ± 0.02* | 40.4 ± 1.30 | 603 ± 26.4* | ||
Dodecanoic acid | LSBJ | 1.31 ± 0.17 | 23.5 ± 5.42 | 303 ± 38.4 | 7.26 |
RSC02 | 1.11 ± 0.03* | 29.3 ± 5.21 | 325 ± 64.0 |